The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?
Submission Deadline: 30 Nov 2021
Guest Editor
Special Issue Information
Dear Colleagues,
In 2021 we are facing several innovations in the field of electrophysiology which are also changing the management of our patients. Regarding the stimulation, we are observing: the increasing use of leadless pacemaker and recently we have also the opportunity to have a leadless VDD pacemaker; the physiologic pacing is becoming more and more popular involving not only His bundle pacing but also left bundle pacing. Focusing on tachyarrhythmias instead, zero-fluoroscopy, high density mapping, epicardial approach e new energy forms are coming out as important options to optimize the treatment.
This Special Issue will be focused on innovations in electrophysiological world, on the clinical relevance of novelties thus far acquired, and on the near future perspectives derived by the changing in the management of our patients.
Prof. Matteo Bertini
Guest Editor
Keywords
- Innovations
- Leadless
- Physiologic pacing
- Zero-fluoro
- High density mapping
- Epicardial approach
- New energy forms
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
Published Papers (7)
Leadless pacemaker implantation in superobese patient
Rev. Cardiovasc. Med. 2022, 23(4), 125; https://doi.org/10.31083/j.rcm2304125
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
Two competing cryoballoon technologies for single shot pulmonary vein isolation: first experiences with the novel system
Rev. Cardiovasc. Med. 2022, 23(4), 118; https://doi.org/10.31083/j.rcm2304118
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
Bridging the future of cardiac stimulation: physiologic or leadless pacing?
Rev. Cardiovasc. Med. 2022, 23(3), 107; https://doi.org/10.31083/j.rcm2303107
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
Leadless pacemaker technology: clinical evidence of new paradigm of pacing
Rev. Cardiovasc. Med. 2022, 23(2), 43; https://doi.org/10.31083/j.rcm2302043
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
Management of macro-reentrant right atrial tachycardia around multiple leads aided by high-density mapping
Rev. Cardiovasc. Med. 2022, 23(1), 1; https://doi.org/10.31083/j.rcm2301001
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
The P wave dispersion—one pixel, one millisecond
Rev. Cardiovasc. Med. 2021, 22(4), 1633–1640; https://doi.org/10.31083/j.rcm2204170
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)
Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis
Rev. Cardiovasc. Med. 2021, 22(3), 557–561; https://doi.org/10.31083/j.rcm2203067
(This article belongs to the Special Issue The technological innovations of the electrophysiological world: are we facing new frontiers of treatment for patients?)